logo.png
Carpal Tunnel Syndrome Market Size to Worth USD 1,328.69 Mn by 2032
May 24, 2024 10:05 ET | Precedence Research
Ottawa, May 24, 2024 (GLOBE NEWSWIRE) -- The global carpal tunnel syndrome market size was valued at USD 942.69 million in 2023 and is predicted to hit around USD 1,232.21 million by 2031, a study...
Picture1
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
February 16, 2021 09:30 ET | PAVmed Inc.
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
SWORD Health to Reli
SWORD Health to Relieve Pandemic-Induced Carpal Tunnel Syndrome by Adding Wrist Therapy to its Virtual Musculoskeletal Care Solution
October 27, 2020 12:08 ET | SWORD Health
NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Complaints of Carpal Tunnel Syndrome and other wrist conditions are on the rise since people bolted from their ergonomically-designed workspaces earlier...
PAVMEDLOGONEW15OCT2018.png
PAVmed Subsidiary Lucid Diagnostics Partners with Fred Hutchinson Cancer Research Center to Evaluate Barrett’s Esophagus (BE) Progression Biomarkers Using EsoCheck™
February 20, 2020 09:30 ET | PAVmed Inc.
Lucid secures exclusive option to license biomarker technology to detect progression from nondysplastic to dysplastic BE using EsoCheck to allow curative ablation before deadly esophageal cancer...
PAVMEDLOGONEW15OCT2018.png
U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test
February 11, 2020 09:30 ET | PAVmed Inc.
NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
patent
USPTO Grants PAVmed Patent Covering its CarpX™ Device
August 21, 2019 09:30 ET | PAVmed Inc.
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the U.S....
PAVMEDLOGONEW15OCT2018.png
PAVmed Provides Business Update
February 26, 2019 07:30 ET | PAVmed Inc.
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
PAVMEDLOGONEW15OCT2018.png
PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update
November 15, 2018 07:30 ET | PAVmed Inc.
Conference call to be held on November 15, 2018 at 4:30 p.m. Eastern time NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on November 15, 2018
November 01, 2018 07:30 ET | PAVmed Inc.
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
October 23, 2018 07:30 ET | PAVmed Inc.
NEW YORK, Oct, Oct. 23, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that...